These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25595117)

  • 21. N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses.
    Papi A; Alfano F; Bigoni T; Mancini L; Mawass A; Baraldi F; Aljama C; Contoli M; Miravitlles M
    Arch Bronconeumol; 2024 May; 60(5):269-278. PubMed ID: 38555190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trial.
    Johnson K; McEvoy CE; Naqvi S; Wendt C; Reilkoff RA; Kunisaki KM; Wetherbee EE; Nelson D; Tirouvanziam R; Niewoehner DE
    Int J Chron Obstruct Pulmon Dis; 2016; 11():799-807. PubMed ID: 27143871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind randomized controlled trial of N-acetylcysteine (NAC) for the treatment of acute exacerbation of chronic obstructive pulmonary disease.
    Kwok WC; Chan SKS; Chiang KY; Ho CMJ
    Respirol Case Rep; 2024 Aug; 12(8):e01449. PubMed ID: 39108325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidation pathway and exacerbations in COPD: the role of NAC.
    Matera MG; Calzetta L; Cazzola M
    Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
    Sadowska AM
    Ther Adv Respir Dis; 2012 Jun; 6(3):127-35. PubMed ID: 22361928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
    Moretti M; Fagnani S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine.
    Santus P; Corsico A; Solidoro P; Braido F; Di Marco F; Scichilone N
    COPD; 2014 Dec; 11(6):705-17. PubMed ID: 24787454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD.
    Powrie DJ; Wilkinson TM; Donaldson GC; Jones P; Scrine K; Viel K; Kesten S; Wedzicha JA
    Eur Respir J; 2007 Sep; 30(3):472-8. PubMed ID: 17504798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations.
    Seemungal TA; Wilkinson TM; Hurst JR; Perera WR; Sapsford RJ; Wedzicha JA
    Am J Respir Crit Care Med; 2008 Dec; 178(11):1139-47. PubMed ID: 18723437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial).
    Malerba M; Ponticiello A; Radaeli A; Bensi G; Grassi V
    Pulm Pharmacol Ther; 2004; 17(1):27-34. PubMed ID: 14643168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of high/low dose N-acetylcysteine on chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Shen Y; Cai W; Lei S; Zhang Z
    COPD; 2014 Jun; 11(3):351-8. PubMed ID: 24378052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of
    Huang C; Kuo S; Lin L; Yang Y
    Ther Adv Respir Dis; 2023; 17():17534666231158563. PubMed ID: 36927162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study.
    Zheng JP; Kang J; Huang SG; Chen P; Yao WZ; Yang L; Bai CX; Wang CZ; Wang C; Chen BY; Shi Y; Liu CT; Chen P; Li Q; Wang ZS; Huang YJ; Luo ZY; Chen FP; Yuan JZ; Yuan BT; Qian HP; Zhi RC; Zhong NS
    Lancet; 2008 Jun; 371(9629):2013-8. PubMed ID: 18555912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
    Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
    COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of high dose N- Acetylcysteine on airway inflammation and quality of life outcomes in adults with bronchiectasis: A randomised placebo-controlled pilot study.
    Jayaram L; King PT; Hunt J; Lim M; Park C; Hu E; Dousha L; Ha P; Bartlett JB; Southcott AM; Muruganandan S; Vogrin S; Rees MA; Dean OM; Wong CA
    Pulm Pharmacol Ther; 2024 Mar; 84():102283. PubMed ID: 38141851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The application of n-acetylcysteine as an antioxidant and mucolytic in mechanical ventilation in intensive care patients. A prospective, randomized, placebo-controlled, double-blind study].
    Konrad F; Schoenberg MH; Wiedmann H; Kilian J; Georgieff M
    Anaesthesist; 1995 Sep; 44(9):651-8. PubMed ID: 7485927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of mucolytics in COPD: A Delphi consensus study.
    Papi A; Avdeev S; Calverley PMA; Cordeiro CR; Jesenak M; Koblížek V; Petkova D; Rogliani P; Tarraf H; Tzanakis N; Ulmeanu R; Uzaslan E; Adir Y
    Respir Med; 2020 Dec; 175():106190. PubMed ID: 33217537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
    Kasielski M; Nowak D
    Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
    Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
    Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations.
    Bathoorn E; Liesker JJ; Postma DS; Boorsma M; Bondesson E; Koëter GH; Kauffman HF; van Oosterhout AJ; Kerstjens HA
    COPD; 2008 Oct; 5(5):282-90. PubMed ID: 18972276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.